Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction
Biomarkers of Heart Failure with Preserved and Reduced Ejection Fraction
Biomarkers are increaingly being used in the management of heart failure not only for the purpose of screening, diagnosis, and risk stratification, but also as a guide to evaluate the response to treatment in the individual patient and as an entry criterion and/or a surrogate marker of efficacy in clinical trials testing novel drugs. In this chapter, we review the role of established biomarkers for heart failure management, according to the main classification of HF phenotypes, based on the measurement of left ventricular ejection fraction, including heart failure with reduced (<40%), preserved (≥50%), and, as recently proposed, mid-range (40-49%) ejection fraction.
Heart Failure, Growth Differentiation Factor 15, Cardio-Renal Syndrome, Interleukin-6, Angiotensin II, Galectin 3, Glycopeptides, Interleukin-18, Interleukin-1 Receptor-Like 1 Protein, Adrenomedullin, C-Reactive Protein, Catecholamines, Biomarkers; Diagnosis; Heart failure management; Prognosis; Screening; Adrenomedullin; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Biomarkers; C-Reactive Protein; Cardio-Renal Syndrome; Catecholamines; Chromogranin A; Creatinine; Galectin 3; Glycopeptides; Growth Differentiation Factor 15; Heart Failure; Hepatitis A Virus Cellular Receptor 1; Humans; Interleukin-1; Interleukin-1 Receptor-Like 1 Protein; Interleukin-18; Interleukin-6; Lipocalin-2; MicroRNAs; Natriuretic Peptide, Brain; Peptide Fragments; Renin; Renin-Angiotensin System; Troponin; Troponin T; Tumor Necrosis Factor-alpha; beta-N-Acetyl-Galactosaminidase; Stroke Volume, Creatinine, Chromogranin A, Humans, Hepatitis A Virus Cellular Receptor 1, Aldosterone, Atrial Natriuretic Factor, Biomarkers, Interleukin-1
Heart Failure, Growth Differentiation Factor 15, Cardio-Renal Syndrome, Interleukin-6, Angiotensin II, Galectin 3, Glycopeptides, Interleukin-18, Interleukin-1 Receptor-Like 1 Protein, Adrenomedullin, C-Reactive Protein, Catecholamines, Biomarkers; Diagnosis; Heart failure management; Prognosis; Screening; Adrenomedullin; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Biomarkers; C-Reactive Protein; Cardio-Renal Syndrome; Catecholamines; Chromogranin A; Creatinine; Galectin 3; Glycopeptides; Growth Differentiation Factor 15; Heart Failure; Hepatitis A Virus Cellular Receptor 1; Humans; Interleukin-1; Interleukin-1 Receptor-Like 1 Protein; Interleukin-18; Interleukin-6; Lipocalin-2; MicroRNAs; Natriuretic Peptide, Brain; Peptide Fragments; Renin; Renin-Angiotensin System; Troponin; Troponin T; Tumor Necrosis Factor-alpha; beta-N-Acetyl-Galactosaminidase; Stroke Volume, Creatinine, Chromogranin A, Humans, Hepatitis A Virus Cellular Receptor 1, Aldosterone, Atrial Natriuretic Factor, Biomarkers, Interleukin-1
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).10 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!